C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 58/100How is this calculated?

TLRY Earnings: EBITDA Growth Still Needs Cash Proof

Tilray’s fiscal 2027 EBITDA outlook improves the earnings narrative, but negative free cash flow, dilution and BrewDog execution remain the decisive equity variables.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.